Lyophilization Technology, Inc. (LTI) is a contract development and manufacturing organisation (CDMO) with deep expertise in all facets of lyophilisation (freeze-drying) for healthcare products. Its capabilities cover a wide array of pharmaceutical, diagnostic and combination products—delivered in containers ranging from vials to dual chamber syringes and cartridges. With a focus on regulatory readiness and scientific rigour, LTI supports its clients across formulation, process design, scale-up, and clinical manufacturing, backed by simulation, characterisation tools and regulatory-compliant documentation.

LTI serves over 500 biotechnology and pharmaceutical organisations—ranging from start-ups to large multi-nationals—and is known for its tailored solutions, strong project oversight, and scientific leadership.

Key Products & Services

Development Sciences: Product design, formulation development, thermal analysis, cycle design & refinement, product characterisation, pilot scale-up.

Clinical Manufacturing: Aseptic fill and finishing for Phase I / II/toxicology materials, process execution in vials and dual-chamber devices, regulatory compliance.

Technical Services: Lyophilization training, consulting, process optimisation and troubleshooting support.

Container & Device Support: Capabilities for vials, dual chamber cartridges & syringes, device integration during cycle and fill operations.

Isolation & Containment: Specialised handling for potent or sensitive products, secure containment infrastructure.

With its specialised focus on lyophilization and a full spectrum of services from early development to clinical manufacture, LTI occupies a distinctive niche in the CDMO landscape. Its combination of scientific depth, regulatory discipline and customised client engagement positions it as a trusted partner for organisations seeking stable, scalable, and high-quality freeze-dried solutions.